论文部分内容阅读
目的:探讨甲巯咪唑联合普萘洛尔治疗甲亢的临床观察。方法:选取2013年10月—2014年3月在我院进行治疗的89例患者作为研究对象,将其治疗效果进行分析。结果:两组临床治疗效果对比具有显著差异,具有统计学意义(P<0.05);治疗前,两组TSH、FT3、FT4水平对比无显著差异,不具有统计学意义(p>0.05),治疗后,两组TSH、FT3、FT4水平对比具有显著差异,具有统计学意义(P<0.05)。结论:甲巯咪唑联合普萘洛尔治疗甲亢效果显著,可改善患者甲状腺激素水平。
Objective: To investigate the clinical observation of thiamazole combined with propranolol in the treatment of hyperthyroidism. Methods: A total of 89 patients treated in our hospital from October 2013 to March 2014 were selected as the research object, and their therapeutic effects were analyzed. Results: Before and after treatment, there was no significant difference in the levels of TSH, FT3 and FT4 between the two groups (P> 0.05), and the difference was statistically significant After the two groups of TSH, FT3, FT4 levels were significantly different, with statistical significance (P <0.05). Conclusion: Methimazole combined with propranolol is effective in treating hyperthyroidism and can improve thyroid hormone level in patients.